Trial description:
Study to develop and validate a sarcoma-specific outcome questionnaire: the Sarcoma Assessment Measure (SAM): , PHASE 2
Contact name:
Dr Helen Hatcher
Trial start date:
Monday, March 18, 2019
Trial end date:
Friday, May 31, 2019
Trial tumour type:
Sarcoma
Show on Radiotherapy:
No
